Share on LinkedInShare on LinkedIn

ARTICLE · 13 DECEMBER 2021

Federal Circuit Finds Written Description For A Claimed Range Not Met By Specific Examples Within The Range

Akin
Akin
Contributor
Akin

Akin

Akin is a global law firm with more than 1,100 lawyers and advisors who pride themselves on...

View firm profile
Explore more from Akin

In a recent decision issued in Indivior UK Limited v. Dr. Reddy's Laboratories, the Federal Circuit affirmed a decision from the PTAB

United StatesIntellectual Property

In a recent decision issued in Indivior UK Limited v. Dr. Reddy's Laboratories, the Federal Circuit affirmed a decision from the PTAB that a limitation to range of polymer weight percentages lacked written description support even though the specification contained specific examples within the range.  

The patent at issue, Indivior's U.S. Patent No. 9,687,454 (the "'454 patent"), generally relates to orally dissolvable films containing therapeutic agents.  The '454 patent issued as a continuation from an application originally filed in 2009.  In 2018, Dr. Reddy's Laboratories petitioned for inter partes review of claims 1-5 and 7-14 of the '454 patent.  The challenged claims  were directed to dissolvable films that include therapeutic agents with a polymeric matrix defined according to its weight percentage.  Specifically, claim 1 recites a polymeric matrix of about 40-60 percent of weight of the film.  Claims 7 and 12 recite a range of 48.2-58.6%, and claim 8

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from